Section 1: Introduction to Antimicrobial Stewardship (Fellows)
Content in this section is available through 3 eLearning modules with additional supporting documentation.
This section covers 3 main topics. These include:
- An Introduction to Antimicrobial Stewardship
- A Brief Overview of the Side Effects of Antibiotics, and
- The Role of Diagnostics in Antimicrobial Stewardship
There is a handout highlighting Core AS Concepts that are introduced in this section. Knowledge check questions embedded in the eLearning also provide a mechanism to assess understanding of concepts.
Target Audience
Fellows/Trainees in Antimicrobial Stewardship Training Program
Learning Objectives
Upon completion of this section, you will be able to:
- Define antimicrobial stewardship, its programmatic goals, and key strategies to achieve the goals
- Relate trends and patterns between antimicrobial use and resistance
- Recognize adverse events associated with the use of specific antimicrobials, including the risk for development of C. difficile infections
- Describe the role of clinical and laboratory diagnostic tools in improving antimicrobial use
- Define expected outcomes of an ASP
Additional Information
Attachment | Size |
---|---|
2019 AS Core Concepts | 121.44 KB |
AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found
Name | Individual's Role in Activity | Name of Commercial Interest | Nature of Relationship |
---|---|---|---|
Abbo, Lillian | Workgroup member | Pfizer Brazil | Honoraria |
Advani, Sonali | Workgroup member | Nabriva Therapeutics | Advisory/Consultant Role |
Amstrong, Wendy | Workgroup member | None | |
Barsoumian, Alice | Workgroup member | None | |
Beeler, Cole | Workgroup member | None | |
Bystritsky, Rachel | Workgroup member | None | |
Cherabuddi, Kartik | Workgroup member | Gatorade | Start - up Research Fund |
NIH (Medimmune) | Research Grant | ||
Cohen, Seth | Workgroup member | None | |
Hamilton, Keith | Workgroup member | None | |
Ince, Dilek | Workgroup member | Ansun Pharma | Research Grant |
Justo, Julie Ann | Workgroup member | None | |
Logan, Ashleigh | Staff | None | |
Luther, Vera | Workgroup member | None | |
Lynch, John | Workgroup member | Astellas Pharmaceuticals, Juno Therapeutics | Advisory/Consultant Role |
Nori, Priya | Workgroup member | None | |
Ohl, Christopher | Workgroup member | Paratek, Bayer, Cempra Pharmaceuticals | Advisory/Consultant Role |
Patel, Payal | Workgroup member | None | |
Pottinger, Paul | Workgroup member | McGraw Hill, Elsevier | Honoraria |
Schwartz, Brian | Workgroup member | None | |
Spicer, Jennifer | Workgroup member | None | |
Stack, Conor | Workgroup member | None | |
Zhou, Yuan | Workgroup member | None | |
Shnekendorf, Rachel | Staff | None |